These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 14607016)
21. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA. McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977 [TBL] [Abstract][Full Text] [Related]
22. Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers. Wilner KD; Rushing M; Walden C; Adler R; Eskra J; Noveck R; Vargas R J Clin Pharmacol; 2002 Sep; 42(9):1027-30. PubMed ID: 12211219 [TBL] [Abstract][Full Text] [Related]
23. Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. Fiorucci S; Mencarelli A; Meneguzzi A; Lechi A; Renga B; del Soldato P; Morelli A; Minuz P J Am Coll Cardiol; 2004 Aug; 44(3):635-41. PubMed ID: 15358033 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, hydrolysis kinetics and anti-platelet effects of isosorbide mononitrate derivatives of aspirin. Gilmer JF; Moriarty LM; McCafferty DF; Clancy JM Eur J Pharm Sci; 2001 Oct; 14(3):221-7. PubMed ID: 11576827 [TBL] [Abstract][Full Text] [Related]
25. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). Violi F; Praticò D; Iuliano L; Balsano F J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906 [TBL] [Abstract][Full Text] [Related]
26. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100. Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939 [TBL] [Abstract][Full Text] [Related]
27. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests. Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752 [TBL] [Abstract][Full Text] [Related]
28. Increased sensitivity to ADP-aggregation in aspirin treated patients with recurrent ischemic stroke? Mattiasson I; Lethagen S; Hillarp A Int Angiol; 2003 Sep; 22(3):239-42. PubMed ID: 14612850 [TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation. Galliard-Grigioni KS; Reinhart WH Eur J Pharmacol; 2009 May; 609(1-3):96-9. PubMed ID: 19272375 [TBL] [Abstract][Full Text] [Related]
30. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493 [TBL] [Abstract][Full Text] [Related]
31. Aspirin sensitivity of platelet aggregation in diabetes mellitus. Albert SG; Hasnain BI; Ritter DG; Joist JH; Mooradian AD Diabetes Res Clin Pract; 2005 Nov; 70(2):195-9. PubMed ID: 15894396 [TBL] [Abstract][Full Text] [Related]
32. Aspirin failure in patients presenting with acute cerebrovascular ischaemia. Halawani SH; Williams DJ; Adefurin A; Webster J; Greaves M; Ford I Thromb Haemost; 2011 Aug; 106(2):240-7. PubMed ID: 21544317 [TBL] [Abstract][Full Text] [Related]
33. Do proton pump inhibitors attenuate the effect of aspirin on platelet aggregation? A randomized crossover study. Adamopoulos AB; Sakizlis GN; Nasothimiou EG; Anastasopoulou I; Anastasakou E; Kotsi P; Karafoulidou A; Stergiou GS J Cardiovasc Pharmacol; 2009 Aug; 54(2):163-8. PubMed ID: 19568178 [TBL] [Abstract][Full Text] [Related]
34. Effect of aspirin dose, preparation, and withdrawal on platelet response in normal volunteers. Coleman JL; Alberts MJ Am J Cardiol; 2006 Sep; 98(6):838-41. PubMed ID: 16950199 [TBL] [Abstract][Full Text] [Related]
35. Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Dichiara J; Bliden KP; Tantry US; Chaganti SK; Kreutz RP; Gesheff TB; Kreutz Y; Gurbel PA Platelets; 2007 Sep; 18(6):414-23. PubMed ID: 17763150 [TBL] [Abstract][Full Text] [Related]
36. Platelet inhibition by single low-dose aspirin, using the newly developed aggregometry with the laser light scattering method. Haque SF; Izumi S; Hotta A; Matsubayashi H; Awaji H; Murano T; Yoshitake T; Yoshikata K; Sugi T; Nakazawa H; Ly C; Makino T Tokai J Exp Clin Med; 2004 Apr; 29(1):7-12. PubMed ID: 15449806 [TBL] [Abstract][Full Text] [Related]
37. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects. Taylor ML; Stewart GA; Thompson PJ Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399 [TBL] [Abstract][Full Text] [Related]
38. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration. Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971 [TBL] [Abstract][Full Text] [Related]
39. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
40. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Watala C; Ulicna O; Golanski J; Nocun M; Waczulíková I; Markuszewski L; Drzewoski J Blood Coagul Fibrinolysis; 2006 Mar; 17(2):113-24. PubMed ID: 16479193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]